Works matching IS 03407004 AND DT 2012 AND VI 61 AND IP 5

Results: 15

Long-term proliferation of functional human NK cells, with conversion of CD56 NK cells to a CD56 phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 615, doi. 10.1007/s00262-011-1122-3

By:

Dowell, Alexander;
Oldham, Kimberley;
Bhatt, Rupesh;
Lee, Steven;
Searle, Peter

Publication type:

Article

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 629, doi. 10.1007/s00262-011-1081-8

By:

Chu, Christina;
Boyer, Jean;
Schullery, Daniel;
Gimotty, Phyllis;
Gamerman, Victoria;
Bender, James;
Levine, Bruce;
Coukos, George;
Rubin, Stephen;
Morgan, Mark;
Vonderheide, Robert;
June, Carl

Publication type:

Article

Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 643, doi. 10.1007/s00262-011-1125-0

By:

Hamilton, Melisa;
Banáth, Judit;
Lam, Vivian;
LePard, Nancy;
Krystal, Gerald;
Bennewith, Kevin

Publication type:

Article

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 655, doi. 10.1007/s00262-011-1124-1

By:

Zhou, Jun;
Yuen, Noah;
Zhan, Qian;
Velazquez, Elsa;
Murphy, George;
Giobbie-Hurder, Anita;
Hodi, F.

Publication type:

Article

Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 667, doi. 10.1007/s00262-011-1132-1

By:

Harashima, Nanae;
Inao, Tohko;
Imamura, Ryu;
Okano, Shinji;
Suda, Takashi;
Harada, Mamoru

Publication type:

Article

A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 677, doi. 10.1007/s00262-011-1135-y

By:

Lin, Jinpiao;
Huo, Rongfen;
Wang, Li;
Zhou, Zhou;
Sun, Yue;
Shen, Baihua;
Wang, Rongfang;
Li, Ningli

Publication type:

Article

The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 689, doi. 10.1007/s00262-011-1129-9

By:

Wood, Laurence;
Pan, Zhen-Kun;
Seavey, Matthew;
Muthukumaran, Geetha;
Paterson, Yvonne

Publication type:

Article

Scutellaria extract and wogonin inhibit tumor-mediated induction of T cells via inhibition of TGF-β1 activity.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 701, doi. 10.1007/s00262-011-1130-3

By:

Dandawate, Sagar;
Williams, Linford;
Joshee, Nirmal;
Rimando, Agnes;
Mittal, Sandeep;
Thakur, Archana;
Lum, Lawrence;
Parajuli, Prahlad

Publication type:

Article

Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 713, doi. 10.1007/s00262-011-1133-0

By:

Snook, Adam;
Magee, Michael;
Marszalowicz, Glen;
Schulz, Stephanie;
Waldman, Scott

Publication type:

Article

Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 725, doi. 10.1007/s00262-011-1182-4

By:

Ullenhag, Gustav;
Sadeghi, Arian;
Carlsson, Björn;
Ahlström, Håkan;
Mosavi, Firas;
Wagenius, Gunnar;
Tötterman, Thomas

Publication type:

Article

Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011.

Published in:

2012

By:

Aptsiauri, Natalia;
Cabrera, Teresa;
Garcia-Lora, Angel;
Garrido, Federico

Publication type:

Report

Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 599, doi. 10.1007/s00262-012-1222-8

By:

Ioannou, Kyriaki;
Samara, Pinelopi;
Livaniou, Evangelia;
Derhovanessian, Evelyna;
Tsitsilonis, Ourania

Publication type:

Article

Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 733, doi. 10.1007/s00262-012-1227-3

By:

Shahabi, Vafa;
Whitney, Gena;
Hamid, Omid;
Schmidt, Henrik;
Chasalow, Scott;
Alaparthy, Suresh;
Jackson, Jeffrey

Publication type:

Article

Comment on 'Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy' by Gustav J. Ullenhag et al.

Published in:

2012

By:

Svane, Inge

Publication type:

Letter

Response to the letter to the editors from Inge Marie Svane on our manuscript 'Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy'.

Published in:

2012

By:

Wagenius, Gunnar;
Ullenhag, Gustav;
Tötterman, Thomas

Publication type:

Letter